Floatz logo

IMMUNOGLOBULIN G4, ANTI-(HUMAN LYSYL OXIDASE HOMOLOG 2) (HUMAN-MUS MUSCULUS MONOCLONAL GS-6624 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GS-6624 .KAPPA.-CHAIN, DIMER

Sickle Cell Disease

New York Universitymonoclonal_antibodyN/AActive
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

134 Active assets in the Sickle Cell Disease cohort.

Asset / SponsorPhaseRating
Glutamine
Ain Shams University
Phase 4BBB
Hydroxyurea
St. Jude Children's Research Hospital
Phase 4BB
Crizanlizumab
Novartis Pharmaceuticals
Phase 4BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 4BB
MAGNESIUM METALLICUM
Medical College of Wisconsin
Phase 3BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G4, ANTI-(HUMAN LYSYL OXIDASE HOMOLOG 2) (HUMAN-MUS MUSCULUS MONOCLONAL GS-6624 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GS-6624 .KAPPA.-CHAIN, DIMER is also rated in:

fibrotic liver diseaseDormant
CCC
Indicative ·
53 / 100
View asset →
hepatitis C virus infectionDormant
CCC
Indicative ·
50 / 100
View asset →
HIV infectious diseaseDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →